Salute e Benessere

A Success Story - DelveInsight's Strategic Support to a Biopharma Leader in…

Interested in getting the patient-based market forecasting report on the NSCLC market? Download sample Interested in getting the patient-based market forecasting report on the NSCLC market? Download sample Challenges Faced by the Client in NSCLC Epidemiology Forecasting: The client, a prominent player in oncology, sought to advance their pipeline of NSCLC therapies by leveraging precise epidemiological data. They required detailedbiomarker-specific segmentationto...
PR Newswire
24/04/2025

IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2−…

Pfizer's IBRANCE (palbociclib) Overview Pfizer's IBRANCE (palbociclib) Overview IBRANCE is an oral medication that inhibits CDKs 4 and 6, which are crucial regulators of the cell cycle that drive cellular progression. In the U.S., IBRANCE is approved for treating adult patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is used in combination with an aromatase inhibitor as a first-line endocrine...
PR Newswire
24/04/2025

GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update

Cash and cash equivalents totaled €81.8 million as of December 31, 2024. In addition, completion in early 2025 of: (i) a non-dilutive royalty financing agreement for up to €185 million including a first installment of €130 million and (ii) the debt repurchase offerNet profit of €1.5 million thanks to revenues amounting to €67.0 million for the period ended December 31, 2024, including a €48.7 million milestone payment and royaltiesIn 2024, Iqirvo® received marketing approval in PBC...
Nasdaq GlobeNewswire
24/04/2025

Inventiva announces the publication in Clinical Gastroenterology and Hepatology…

► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis► The biomarker signatures developed for fibrosis improvement, MASH resolution and composite histological endpoints, suggested better predictive accuracy than other diagnostic scores available including FIB4, FIBC3, ABC3D, NFS, ELF and MACK-3► The biomarker signatures suggested strong predictive accuracy, with AUROC values above 0.80 that may indicate...
Nasdaq GlobeNewswire
24/04/2025

Casino Group: Confirmation of a repayment to Quatrim secured bondholders

Confirmation of a repayment to Quatrim secured bondholders Paris, 24 April 2025Casino Group announces that it has repaid, on April 24, 2025, €56.0 m of the secured debtcarried by its subsidiary Quatrim, including €55.8 m of principal and €0.2 m of accrued interest.This transaction reduces, the nominal amount of the Quatrim secured bonds to €221 m.This repayment brings to €99 million the total payments made to holders of Quatrim secured debt since the beginning of 2025 (€30 million...
Nasdaq GlobeNewswire
24/04/2025

Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million

Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 MillionHalle (Saale) / Munich, Germany, April 24, 2025– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (“ Vivoryon ” or the “ Company ”), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of pathologically altered proteins, today announced that it has entered into a Standby Equity Purchase Agreement (“SEPA”) of up...
Nasdaq GlobeNewswire
24/04/2025

Guerbet: Q1 2025 revenue

Q1 2025 revenueQuarterly activityRevenue: €180.1m, down 7.1% at CER 1and on a like-for-like basis 2 As expected, a first quarter marked by a persistent impact on France and a penalizing base effectDeclining momentum in Diagnostic Imaging (-8.7% at CER and on a like-for-like basis) and growing in Interventional Imaging (+5.8% at CER and on a like-for-like basis)Annual targets confirmedFurther growth in profitability: restated EBITDA margin 3expected to exceed...
Nasdaq GlobeNewswire
24/04/2025

PCI Biotech Holding ASA: Annual Report 2024

The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2024. Please find the report attached, as well as the report according to the European Single Electronic Format (ESEF). The Annual Report 2024 is also available on the company's website www.pcibiotech.com.For further information, please contact: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo Ronny Skuggedal, CEO, [email protected], Mobile: +47 940 05 757This information is...
Nasdaq GlobeNewswire
24/04/2025

Home Centre turns other brands' ads into their own

The campaign, created by Publicis Middle East, identifies commercials from other brands where Home Centre furniture and accessories make an appearance. Then, with strategically targeted YouTube pre-rolls, Home Centre steals the attention, letting viewers know its products are featured in the next ad they're about to watch, acting as a cheeky hijack of other brands' time, effort, and money spent. Their production, their budgets, their media, their audience, is now Home Centre's spotlight. The...
PR Newswire
24/04/2025

Metal Forging Market to Reach $195.6 billion, Globally, by 2034 at 7.3% CAGR…

Prime determinants of growth Prime determinants of growth The metal forging market is expected to witness notable growth owing to the expansion in the automotive and aerospace industry and growth in the energy sector. Moreover, the adoption of industry 4.0 technology is expected to provide lucrative opportunity for the growth of the market during the forecast period. On the contrary, limitations of metal forging costs limit the growth of the metal forging market. Download PDF Sample...
PR Newswire
24/04/2025

Oral Proteins & Peptides Market worth US$24.00 billion by 2030 with 22.1% CAGR |…

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194705708 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=194705708 Browse in-depth TOC on "Oral Proteins & Peptides Market" 410 - Tables52 - Figures323 - Pages By semaglutide segment,the oral proteins and peptides market is segmented by molecule into several categories, including trofinetide, semaglutide, linaclotide, voclosporin, plecanatide,...
PR Newswire
24/04/2025

Koelis Announces Partnership with Bot Image™ at AUA 2025

New AI Technology Will Improve Prostate Biopsy Accuracy and Procedure Workflow ®MRI-fusion guidance system with the Bot Image ProstatID™ system, the first FDA-cleared software for screening, detection and diagnosis of prostate cancer using fully automated AI-based lesion detection, classification and 3D contouring.Koelis will be holding live and interactive demos at its AUA booth #1259 from April 25 thto 28 th.The Bot Image™ Partnership reinforces Koelis' commitment to both prostate...
Nasdaq GlobeNewswire
24/04/2025

At-Home Genetic Testing Market to Reach $4.5 Bn By 2027 in the short run and…

Market Introduction Market Introduction The at-home genetic testing market refers to the genetic testing that enables individuals to collect DNA samples typically via saliva or cheek swabs from the comfort of their homes and send them to certified laboratories for analysis. These tests provide insights into ancestry, health predispositions, carrier status for genetic conditions, and even wellness traits. Over the past decade, the market has seen significant growth due to increasing...
PR Newswire
24/04/2025

Abu Dhabi Pioneers Collaborative Approach to Responsible AI in Healthcare at…

His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, added: "AI is not tomorrow's technology, it is today's reality. While many of us are adapting to its rise, our children will grow up with it as the norm. That's why the decisions we make today, around ethics, equity, and safety, must be made together. Through this declaration, we will establish a globally accessible guideline that extends beyond borders and commercial interests. This document is a…
PR Newswire
24/04/2025

Aily Labs Expands Board and Advisory Board with AI and Industry Heavyweights to…

Amy Chang Appointed to Aily Labs' Board of Directors and Advisory Board Amy Chang Appointed toAily Labs'Board of Directors and Advisory Board Ms. Chang serves on the Boards of Disney and Procter & Gamble (P&G), bringing a proven track record in digital transformation, product innovation, and scaling high-growth technology companies. She was the founder and CEO of Accompany, Inc., acquired by Cisco, where she later led its multi-billion-dollar Collaboration business. Previously,...
PR Newswire
24/04/2025

Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with…

Presentations will be delivered by experts from a wide variety of leading research groups including Pfizer, GSK, and Bio-Techne, along with co-hosts IPA, ACROBiosystems, and Curia. SALT LAKE CITY, April24, 2025(GLOBE NEWSWIRE) -- Carterra Inc., the world leader in enabling high-throughput biology, is partnering with co-hosts ImmunoPrecise Antibodies (IPA), ACROBiosystems, and Curia to offer its 2025 symposia series titled, “ Unlocking High-Throughput Biology in Drug Discovery...
Nasdaq GlobeNewswire
24/04/2025

Avidicure Launches with $50 Million in Seed Financing to Develop New…

AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple other cancer indicationsThe company will present at upcoming medical meetings, AACR and ASCOAMSTERDAM, April24, 2025(GLOBE NEWSWIRE) -- Avidicure, a biotechnology company pioneering an entirely new multifunctional antibody...
Nasdaq GlobeNewswire
24/04/2025

Endo's New Spatial Computing Injection Simulator for Peyronie's Disease Creates…

"We know that healthcare providers value hands-on approaches to learning, and technology like the Spatial Computing Injection Simulator can make a huge difference for the surgeons and advanced practice providers who treat Peyronie's disease," said Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo. "With a mix of tactical practice, videos of real procedures, and the inclusion of practical information, the simulator is an example of innovation…
PR Newswire
24/04/2025

BioNTech to Present Clinical and Preclinical Data Across mRNA and…

MAINZ, Germany, April 24, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data for selected assets from its diversified oncology pipeline, including mRNA cancer immunotherapies, next-generation immunomodulators, and targeted therapies, at the American Association for Cancer Research (“AACR”) Annual Meeting held in Chicago, Illinois from April 25-30, 2025. The oral and poster presentations underline both the progress of BioNTech's advanced priority oncology...
Nasdaq GlobeNewswire
24/04/2025

Novo Holdings and EIFO invest €48 million in HealthCap IX to strengthen the…

HealthCap is a longstanding and recognised venture firm with a strong presence in the Nordics. Since its founding in 1996, it has built a strong track record of supporting companies that address serious medical conditions through novel therapeutic approaches. With investments in more than 130 companies, HealthCap has played a central role in developing over 30 approved pharmaceutical products and more than 50 innovative medical technologies – benefitting millions of patients globally…
PR Newswire
24/04/2025

New survey shows that over 90% of animal owners trust and appreciate veterinary…

New survey data show 94% of animal owners appreciate the work of veterinarians 1, compared to only 49% of veterinary professionals feeling their profession is appreciated, among other findings. 2 The survey confirms differences in perspectives: 65% of animal owners think veterinarians have a good work-life balance 1while 48% of veterinarians say animal owners underappreciate the way they trade-off their work-life-balance to help animals. 2 On World Veterinary Day 2025, Boehringer...
Nasdaq GlobeNewswire
24/04/2025

Composition of the Nomination Committee of Orion Corporation

ORION CORPORATIONSTOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 24 APRIL 2025 at 11.00 EEST Composition of the Nomination Committee of Orion Corporation The Board of Directors of Orion Corporation has appointed the following persons to the Nomination Committee of the company: Annika EkmanPetteri KarttunenRisto KarvonenVeli-Matti MattilaHilpi RautelinSeppo Salonen Hilpi Rautelin was appointed as Chair of the...
Nasdaq GlobeNewswire
24/04/2025

OMRON Healthcare Donates 4,000 Blood Pressure Monitors and Advances AFib…

Logo: https://kyodonewsprwire.jp/img/202504177579-O1-SWNJGnOc Logo:https://kyodonewsprwire.jp/img/202504177579-O1-SWNJGnOc OMRON Healthcare has partnered with MMM since 2017 to promote and help to create awareness of the dangers of raised blood pressure and hypertension and to date has donated approximately 30,000 blood pressure monitors across 100 countries. Now, in its seventh year running, this initiative has been crucial in educating hypertensive patients to measure their blood...
PR Newswire
24/04/2025

iSTAR Medical's MINIject® demonstrates significant sustained 5-year efficacy in…

For immediate release iSTAR Medical's MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial Five-year safety profile including corneal health confirmed and 38% IOP reduction sustained Over 5000 patients benefiting from limited commercial rollout of MINIject® worldwide to-dateiSTAR Medical to advance MINIject® independently following ending of AbbVie partnership WAVRE, Belgium — 24 April 2025 :iSTAR Medical,...
Nasdaq GlobeNewswire
24/04/2025
Altri  Comunicati